Incyte Corp (INCY)
51.13
-0.61
(-1.18%)
USD |
NASDAQ |
Apr 25, 13:44
Incyte Price: 51.13 for April 25, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 24, 2024 | 51.65 | 51.84 | 51.14 | 51.74 | 1.543M |
| Apr 23, 2024 | 52.00 | 52.22 | 51.39 | 51.65 | 2.494M |
| Apr 22, 2024 | 52.43 | 52.62 | 51.88 | 51.92 | 1.752M |
| Apr 19, 2024 | 52.97 | 53.00 | 52.00 | 52.35 | 2.181M |
| Apr 18, 2024 | 52.96 | 53.15 | 52.26 | 52.82 | 1.830M |
| Apr 17, 2024 | 53.22 | 53.80 | 52.70 | 52.72 | 2.526M |
| Apr 16, 2024 | 53.34 | 54.09 | 53.15 | 53.22 | 1.465M |
| Apr 15, 2024 | 53.91 | 54.30 | 53.41 | 53.43 | 1.574M |
| Apr 12, 2024 | 54.72 | 55.03 | 53.76 | 53.85 | 1.227M |
| Apr 11, 2024 | 55.34 | 55.99 | 54.63 | 54.92 | 1.581M |
| Apr 10, 2024 | 54.85 | 55.25 | 54.47 | 55.00 | 1.053M |
| Apr 09, 2024 | 55.20 | 56.46 | 55.19 | 55.30 | 1.483M |
| Apr 08, 2024 | 54.97 | 55.42 | 54.42 | 55.05 | 1.239M |
| Apr 05, 2024 | 54.84 | 55.41 | 54.26 | 55.24 | 1.603M |
| Apr 04, 2024 | 55.55 | 55.86 | 54.82 | 54.99 | 1.546M |
| Apr 03, 2024 | 55.84 | 56.21 | 55.00 | 55.31 | 1.910M |
| Apr 02, 2024 | 56.56 | 57.15 | 55.79 | 55.83 | 2.089M |
| Apr 01, 2024 | 56.97 | 57.00 | 56.03 | 56.64 | 1.270M |
| Mar 28, 2024 | 57.25 | 57.40 | 56.61 | 56.97 | 1.883M |
| Mar 27, 2024 | 56.52 | 57.35 | 56.50 | 57.12 | 1.654M |
| Mar 26, 2024 | 57.53 | 57.56 | 56.51 | 56.55 | 1.806M |
| Mar 25, 2024 | 57.14 | 57.59 | 56.57 | 57.48 | 1.883M |
| Mar 22, 2024 | 57.98 | 57.98 | 56.96 | 56.98 | 1.193M |
| Mar 21, 2024 | 58.57 | 59.03 | 57.47 | 57.72 | 1.536M |
| Mar 20, 2024 | 58.03 | 58.43 | 57.49 | 58.24 | 1.714M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
51.13
Minimum
Apr 25 2024
109.69
Maximum
Jul 20 2020
76.52
Average
77.10
Median
Price Benchmarks
| Novartis AG | 98.96 |
| MorphoSys AG | 18.13 |
| Illumina Inc | 120.00 |
| Biogen Inc | 201.35 |
| Pfizer Inc | 25.48 |
Price Related Metrics
| PE Ratio | 19.29 |
| PS Ratio | 3.126 |
| PEG Ratio | 0.2595 |
| Price to Book Value | 2.212 |
| Price to Free Cash Flow | 25.73 |
| Earnings Yield | 5.18% |
| Market Cap | 11.48B |
| PEGY Ratio | 0.2595 |
| Operating PE Ratio | 17.78 |
| Normalized PE Ratio | 19.63 |